Cargando…

Twenty-Four-Hour Intraocular Pressure Control with Omidenepag Isopropyl 0.002% in Patients with Glaucoma and Ocular Hypertension

PURPOSE: To clarify the intraocular pressure (IOP)-lowering effect of a selective prostanoid EP2 receptor agonist, omidenepag isopropyl (OMDI) during a 24-hour period. PATIENTS AND METHODS: Subjects aged ≥20 years and with diagnosed, untreated primary open-angle glaucoma or ocular hypertension were...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shiratori, Naka, Nishio, Yusuke, Takeda, Ayaka, Sugimoto, Shio, Takazawa, Kenji, Otsuka, Naomi, Ishida, Naruhiro, Shii, Daisuke, Hori, Kiyotaka, Nakamoto, Kenji
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8500489/ https://www.ncbi.nlm.nih.gov/pubmed/34675468 http://dx.doi.org/10.2147/OPTH.S333042

Ejemplares similares

Efficacy and Safety of Omidenepag Isopropyl 0.002% Ophthalmic Solution: A Retrospective Analysis of Real-World Data in Japan
por: Miki, Atsuya, et al.
Publicado: (2022)

Evaluation of Patterns and Correlations of the Degree of Conjunctival Hyperemia Induced by Omidenepag Isopropyl 0.002% and Ripasudil 0.4%
por: Terao, Etsuko, et al.
Publicado: (2020)

Time course of conjunctival hyperemia induced by omidenepag isopropyl ophthalmic solution 0.002%: a pilot, comparative study versus ripasudil 0.4%
por: Terao, Etsuko, et al.
Publicado: (2020)

A Randomized Phase 2 Trial Comparing Omidenepag Isopropyl 0.002% Once and Twice Daily in Subjects With Primary Open-angle Glaucoma or Ocular Hypertension (SPECTRUM-6)
por: Olander, Kenneth W., et al.
Publicado: (2021)

Short-Term Efficacy and Safety of Omidenepag Isopropyl in Patients with Normal-Tension Glaucoma
por: Inoue, Kenji, et al.
Publicado: (2020)

Efficacy and Patient Tolerability of Omidenepag Isopropyl in the Treatment of Glaucoma and Ocular Hypertension
por: Matsuo, Masato, et al.
Publicado: (2022)

Interim Results of Post-Marketing Observational Study of Omidenepag Isopropyl for Glaucoma and Ocular Hypertension in Japan
por: Nakazawa, Toru, et al.
Publicado: (2022)

Cystoid macular edema associated with omidenepag isopropyl in a phakic eye with an implantable collamer lens: a case report
por: Bae, Byung-Jin, et al.
Publicado: (2023)

Effects of the Selective EP2 Receptor Agonist Omidenepag on Adipocyte Differentiation in 3T3-L1 Cells
por: Yamamoto, Yasuko, et al.
Publicado: (2020)

The Antiglaucoma Agent and EP2 Receptor Agonist Omidenepag Does Not Affect Eyelash Growth in Mice
por: Esaki, Yoshihiko, et al.
Publicado: (2020)

Pharmacokinetics, Safety, and Intraocular Pressure-Lowering Profile of Omidenepag Isopropyl, a Selective, Nonprostaglandin, Prostanoid EP2 Receptor Agonist, in Healthy Japanese and Caucasian Volunteers (Phase I Study)
por: Aihara, Makoto, et al.
Publicado: (2019)

Measurements of the nucleon structure function in the range 0.002 $<$ x $<$ 0.17 and 0.2 $<$ Q$^{2}$ $<$ 8 GeV$^{2}$ in deuterium, carbon and calcium
por: Arneodo, M, et al.
Publicado: (1989)

One-Year Follow-Up Study of Changes in Prostaglandin-Associated Periorbital Syndrome After Switch From Conventional Prostaglandin F2alfa to Omidenepag Isopropyl
por: Oogi, Satomi, et al.
Publicado: (2020)

Evaluation of early medication persistence with omidenepag isopropyl, a topical selective prostaglandin EP2 agonist, in patients with glaucoma: a retrospective two-institute study
por: Nakakura, Shunsuke, et al.
Publicado: (2021)

Omidenepag Isopropyl in Latanoprost Low/Nonresponders With Primary Open Angle Glaucoma or Ocular Hypertension: A Phase 3, Nonrandomized, Two-Phase, Open-Label Study
por: Panarelli, Joseph F., et al.
Publicado: (2023)

Statistical Analysis of Factors Affecting Surgically Induced Astigmatism Following Trabeculectomy
por: Shiratori, Naka, et al.
Publicado: (2022)

Genome Sequence of Pasteurella multocida Razi 0002 of Avian Origin
por: Sprague, Lisa D., et al.
Publicado: (2017)

Comparison of the Drug-Induced Efficacies between Omidenepag Isopropyl, an EP2 Agonist and PGF2α toward TGF-β2-Modulated Human Trabecular Meshwork (HTM) Cells
por: Suzuki, Soma, et al.
Publicado: (2022)

A Reference Proteomic Database of Lactobacillus plantarum CMCC-P0002
por: Zhu, Li, et al.
Publicado: (2011)

Improved Crystallinity of Annealed 0002 AlN Films on Sapphire Substrate
por: Bersch, Bruno Comis, et al.
Publicado: (2023)

Cloning, expression and characterization of a chitinase from Paenibacillus chitinolyticus strain UMBR 0002
por: Liu, Cong, et al.
Publicado: (2020)

Downregulation of COL12A1 and COL13A1 by a selective EP2 receptor agonist, omidenepag, in human trabecular meshwork cells
por: Kumon, Masashi, et al.
Publicado: (2023)

Effect of Prostaglandin E2 Agonist Omidenepag on the Expression of Matrix Metalloproteinase in Trabecular Meshwork Cells
por: Kim, Jeong Yeub, et al.
Publicado: (2022)

Twenty-Four-Hour Variation of Intraocular Pressure in Primary Open-Angle Glaucoma Treated with Triple Eye Drops
por: Itoh, Yoshinori, et al.
Publicado: (2017)

A New MiRNA MiRm0002 in Eggplant Participates in the Regulation of Defense Responses to Verticillium Wilt
por: Zhu, Wenjiao, et al.
Publicado: (2021)

A comparison of continuous infusion and intermittent bolus administration of 0.1% ropivacaine with 0.0002% fentanyl for epidural labor analgesia
por: Patkar, Chinmayi Surendra, et al.
Publicado: (2015)

The Purification, Characterization, and Biological Activity of New Polyketides from Mangrove-Derived Endophytic Fungus Epicoccum nigrum SCNU-F0002
por: Yan, Zhangyuan, et al.
Publicado: (2019)

Study on the growth of Al-doped ZnO thin films with (112̄0) and (0002) preferential orientations and their thermoelectric characteristics
por: Luo, Jing-Ting, et al.
Publicado: (2018)

Omidenepag, a Selective, Prostanoid EP2 Agonist, Does Not Suppress Adipogenesis in 3D Organoids of Human Orbital Fibroblasts
por: Hikage, Fumihito, et al.
Publicado: (2021)

N-Isopropylbenzamide
por: van Oosten, Erik M., et al.
Publicado: (2008)

Higgs Boson Searches at LHC 002
por: Vivarelli, I
Publicado: (2002)

OR6-002 – Thromboembolism in autoinflammatory syndromes
por: Vaitla, PM, et al.
Publicado: (2013)

AB002. Biomarkers for prostate cancer
por: Shindel, Alan
Publicado: (2016)

Effects of selective EP2 receptor agonist, omidenepag, on trabecular meshwork cells, Schlemm’s canal endothelial cells and ciliary muscle contraction
por: Nakamura, Natsuko, et al.
Publicado: (2021)

Aggregation-Induced Expansion of Poly-(N-isopropyl acrylamide) Solutions Observed Directly by the Transient Grating Imaging Technique
por: Kato, Daiki, et al.
Publicado: (2018)

Assessment of cytotoxicity of (N-isopropyl acrylamide) and Poly(N-isopropyl acrylamide)-coated surfaces
por: Cooperstein, Marta A, et al.
Publicado: (2013)

Synthesis of isopropyl-substituted anthraquinones via Friedel–Crafts acylations: migration of isopropyl groups
por: Chakiri, Abdel B., et al.
Publicado: (2017)

Investigation on preferably oriented abnormal growth of CdSe nanorods along (0002) plane synthesized by henna leaf extract-mediated green synthesis
por: Iyyappa Rajan, P., et al.
Publicado: (2018)

Fused multicyclic polyketides with a two-spiro-carbon skeleton from mangrove-derived endophytic fungus Epicoccum nigrum SCNU-F0002
por: Yan, Zhangyuan, et al.
Publicado: (2020)

Omidenepag, a non-prostanoid EP2 receptor agonist, induces enlargement of the 3D organoid of 3T3-L1 cells
por: Ida, Yosuke, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_5i9tef6ms5aee5ob8uispkkpht